$1.16
-0.03-2.52%
At close: -
$1.14
-0.02-1.72%
After Hours: 4:52 PM EDT
Comments
Loading...
Advanced Biomed Analyst Ratings and Price Targets | NASDAQ:ADVB | Benzinga
Advanced Biomed Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Advanced Biomed Corp from these most-recent analyst ratings.
Analyst Ratings for Advanced Biomed
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Advanced Biomed (ADVB) stock?
There is no price target for Advanced Biomed
What is the most recent analyst rating for Advanced Biomed (ADVB)?
There is no analyst for Advanced Biomed
When was the last upgrade for Advanced Biomed (ADVB)?
There is no last upgrade for Advanced Biomed
When was the last downgrade for Advanced Biomed (ADVB)?
There is no last downgrade for Advanced Biomed.
When is the next analyst rating going to be posted or updated for Advanced Biomed (ADVB)?
There is no next analyst rating for Advanced Biomed.
Is the Analyst Rating Advanced Biomed (ADVB) correct?
There is no next analyst rating for Advanced Biomed.
Browse analyst ratings and price targets on all stocks.
